Upstream Bio Inc.

NASDAQ: UPB · Real-Time Price · USD
18.95
0.33 (1.77%)
At close: Aug 15, 2025, 3:59 PM
19.00
0.29%
After-hours: Aug 15, 2025, 05:39 PM EDT

Upstream Bio Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Revenue
2.37M 2.38M 1.21M
Cost of Revenue
89K 60K 7K
Gross Profit
2.37M 2.38M 1.21M
Operating Income
-77.76M -40.11M -23.91M
Interest Income
12.12M 4.17M 205K
Pretax Income
-62.81M -20.54M -23.87M
Net Income
-62.81M -20.54M -23.87M
Selling & General & Admin
17.17M 10.7M 6.46M
Research & Development
62.97M 31.8M 18.66M
Other Expenses
n/a n/a n/a
Operating Expenses
80.13M 42.49M 25.12M
Interest Expense
n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
80.13M 42.49M 25.12M
Income Tax Expense
n/a n/a n/a
Shares Outstanding (Basic)
51.34M 36.32M 36.32M
Shares Outstanding (Diluted)
51.34M 36.32M 36.32M
EPS (Basic)
-1.49 -1.05 -0.66
EPS (Diluted)
-1.49 -1.05 -0.66
EBITDA
-77.67M -40.05M -23.9M
EBIT
-77.76M -40.11M -23.91M
Depreciation & Amortization
89K 60K 7K